The nature of pharmacopoeial specifications for bulk drug substances 25-30 years ago and the analytical methods used at that time are briefly reviewed. Since then the concept of characterizing drug substances by controlling impurities has been developed in pharmacopoeias. This concept is examined in
โฆ LIBER โฆ
REQUIREMENTS OF NEW ANTITUBERCULAR DRUGS FROM THE EXPERIMENTAL POINT OF VIEW
โ Scribed by B. Fust
- Book ID
- 114877030
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 466 KB
- Volume
- 106
- Category
- Article
- ISSN
- 0890-6564
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Purity requirements from a pharmacopoeia
โ
C.A. Johnson
๐
Article
๐
1986
๐
Elsevier Science
๐
English
โ 457 KB
New drugs for rheumatoid arthritis: The
โ
Stephen H. Polmar
๐
Article
๐
2010
๐
Elsevier Science
๐
Spanish
โ 100 KB
New drugs for rheumatoid arthritis: The
โ
Stephen H. Polmar
๐
Article
๐
2010
๐
Elsevier Science
๐
Spanish
โ 171 KB
Required functionality of PACS from clin
โ
F.H. Barneveld Binkhuysen
๐
Article
๐
1992
๐
Elsevier Science
๐
English
โ 436 KB
Fat replacers โ Requirements from a nutr
โ
Grossklaus, Rolf
๐
Article
๐
1996
๐
John Wiley and Sons
โ 727 KB
There is a demand for development of low-fat products including fat replacers to limit the intake of total fat. The objective ofthis review is to show the requirements that are necessary for the assessment of the risks and benefits of a new fat replacer. An ideal fat replacer should be completely sa
Requirements for partial pressure analyz
โ
A. van Oostrom
๐
Article
๐
1972
๐
Elsevier Science
๐
English
โ 423 KB